← Back to Search

Behavioural Intervention

Acupuncture for Sepsis

Phase 2
Recruiting
Led By Gary Deng, MD, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years

Summary

This trial is investigating whether acupuncture can help improve outcomes for people with sepsis. The study will compare real acupuncture to sham acupuncture, which is similar but uses different needles and targets different body sites.

Who is the study for?
This study is for individuals at high risk of developing sepsis, possibly due to conditions like pre-eclampsia. Participants must meet certain health criteria to join, but specific inclusion and exclusion details are not provided.
What is being tested?
The trial is testing whether real acupuncture can improve outcomes in patients at high risk for sepsis compared to sham acupuncture, which mimics the procedure without targeting the same points or using the same needles.
What are the potential side effects?
Acupuncture may cause minor bleeding, bruising, or soreness where the needles enter the skin. There's also a low risk of infection if not done properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants recruited compared to the number of participants who complete study treatment.

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AcupunctureExperimental Treatment1 Intervention
Group II: Sham AcupuncturePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acupuncture
2011
Completed Phase 3
~1240

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,969 Previous Clinical Trials
597,173 Total Patients Enrolled
1 Trials studying Sepsis
126 Patients Enrolled for Sepsis
Gary Deng, MD, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
7 Previous Clinical Trials
658 Total Patients Enrolled
~52 spots leftby Mar 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top